Sheyu Li
Impact in
-
- Diabetes Treatment and Management
- Diabetes Management and Research
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Nephrology top 2%
Papers in
-
- Diabetes Treatment and Management 27
- Diabetes Management and Research 7
- Diabetes, Cardiovascular Risks, and Lipoproteins 7
- Surgery 26
- Lipoproteins and Cardiovascular Health 13
- Co-authors
- Haoming Tian (49 shared papers)Ling Li (16 shared papers)Xin Sun (25 shared papers)Qingyang Shi (21 shared papers)Jiali Liu (6 shared papers)Ke Deng (5 shared papers)Qianrui Li (18 shared papers)Qiukui Hao (9 shared papers)
- Journals
- BMJ (12 papers)Journal of Evidence-Based Medicine (8 papers)Diabetes Obesity and Metabolism (6 papers)PLoS ONE (5 papers)Frontiers in Medicine (4 papers)
- Partner nations
- ChinaCanadaUnited Kingdom
In The Last Decade
Sheyu Li
148 papers receiving 5.3k citations
Sheyu Li's Hit Papers
Peers
Comparison fields: 5 of 149
- Endocrinology, Diabetes and Metabolism 1.8k
- Nephrology 330
- Cardiology and Cardiovascular Medicine 385
- Physiology 397
- Surgery 625
Countries citing papers authored by Sheyu Li
This map shows the geographic impact of Sheyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheyu Li more than expected).
Fields of papers citing papers by Sheyu Li
This network shows the impact of papers produced by Sheyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheyu Li. The network helps show where Sheyu Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Sheyu Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 154 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2021 | 499 |
| 2 | Exercise for sarcopenia in older people: A systematic review and network meta‐analysis Hit paper breakdown → | 2023 | 298 |
| 3 | Mobile App-Based Interventions to Support Diabetes Self-Management: A Systematic Review of Randomized Controlled Trials to Identify Functions Associated with Glycemic Efficacy Hit paper breakdown → | 2017 | 224 |
| 4 | 2017 | 215 | |
| 5 | Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2023 | 212 |
| 6 | 2012 | 201 | |
| 7 | 2016 | 190 | |
| 8 | 2014 | 137 | |
| 9 | 2014 | 134 | |
| 10 | 2019 | 133 | |
| 11 | 2020 | 120 | |
| 12 | 2016 | 119 | |
| 13 | 2019 | 110 | |
| 14 | 2018 | 103 | |
| 15 | PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis Hit paper breakdown → | 2022 | 97 |
| 16 | 2021 | 96 | |
| 17 | Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials Hit paper breakdown → | 2024 | 94 |
| 18 | 2018 | 91 | |
| 19 | 2014 | 80 | |
| 20 | 2015 | 77 |
About Sheyu Li
Sheyu Li is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery, Cardiology and Cardiovascular Medicine, Pharmacology and Nephrology, having authored 154 papers that have together received 5.4k indexed citations. Recurring topics across this work include Diabetes Treatment and Management (27 papers), Lipoproteins and Cardiovascular Health (13 papers), Clinical practice guidelines implementation (7 papers), Diabetes Management and Research (7 papers), Heart Failure Treatment and Management (7 papers), Pharmacology and Obesity Treatment (7 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (7 papers) and Meta-analysis and systematic reviews (6 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (1.8k citations), Nephrology (330 citations), Cardiology and Cardiovascular Medicine (385 citations), Physiology (397 citations) and Surgery (625 citations). Sheyu Li has collaborated with scholars based in China, Canada and United Kingdom. Frequent co-authors include Haoming Tian, Ling Li, Xin Sun, Qingyang Shi, Jiali Liu, Ke Deng, Qianrui Li, Qiukui Hao, Guanjian Liu and Yanjiao Shen. Their work appears in journals such as BMJ, Journal of Evidence-Based Medicine, Diabetes Obesity and Metabolism, PLoS ONE and Frontiers in Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.